Citation profile for Ilan Guedj

Ilan Guedj : Citation Profile

H index

i10 index

Citations

RESEARCH PRODUCTION:

Papers

RESEARCH ACTIVITY:

   1 years (2004 - 2004). See details.
   Cites by year: 51
   Journals where Ilan Guedj has often published
   Relations with other researchers
   Recent citing documents: 3.    Total self citations: 0 (0 %)

MORE DETAILS IN:

EconPapers Author's homepage

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pgu92
   Updated: 2024-04-18    RAS profile: 2021-03-12
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Ilan Guedj.

Is cited by:

Allain, Marie-Laure (7)

Henry, Emeric (7)

Kyle, Margaret (4)

Arora, Ashish (4)

Berkovitz, Tomer (3)

Belenzon, Sharon (3)

Magazzini, Laura (2)

Hvide, Hans (2)

Pammolli, Fabio (2)

Wurgler, Jeffrey (1)

Bobtcheff, Catherine (1)

Cites to:

Zingales, Luigi (3)

Servaes, Henri (3)

Rajan, Raghuram (3)

Scharfstein, David (2)

Stulz, René (2)

Stein, Jeremy (2)

DiMasi, Joseph (1)

Lang, Larry (1)

Lerner, Josh (1)

Jensen, Michael (1)

Main data

Where Ilan Guedj has published?

Recent works citing Ilan Guedj (2024 and 2023)

Year	Title of citing document
2023	Corporate diversification and labor investment efficiency: Evidence from China. (2023). Sun, Mingwei ; Fu, Yumei ; Bai, Min. In: Economic Modelling. RePEc:eee:ecmode:v:127:y:2023:i:c:s0264999323002948. Full description at Econpapers \|\| Download paper
2023	Allocative efficiency of internal capital markets: Evidence from equity carve-outs by diversified firms. (2023). Sudarsanam, Sudi ; Tian, Siyang ; Vitkova, Valeriya. In: International Review of Financial Analysis. RePEc:eee:finana:v:86:y:2023:i:c:s1057521923000169. Full description at Econpapers \|\| Download paper

Works by Ilan Guedj:

Year	Title	Type	Cited
2004	Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms In: NBER Working Papers. [Full Text][Citation analysis]	paper	51